APA

Goto N., Tsurumi H., Takemura M., Matsumoto T., Shibata Y., Mabuchi R., Nakamura N., Nakamura H., Yamada T., Seishima M., Takami T., Takeuchi T. & Moriwaki H. (20150707). Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen. : Journal of clinical and experimental hematopathology : JCEH.

Chicago

Goto Naoe, Tsurumi Hisashi, Takemura Masao, Matsumoto Takuro, Shibata Yuhei, Mabuchi Ryoko, Nakamura Nobuhiko, Nakamura Hiroshi, Yamada Tetsuya, Seishima Mitsuru, Takami Tsuyoshi, Takeuchi Tamotsu and Moriwaki Hisataka. 20150707. Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen. : Journal of clinical and experimental hematopathology : JCEH.

Harvard

Goto N., Tsurumi H., Takemura M., Matsumoto T., Shibata Y., Mabuchi R., Nakamura N., Nakamura H., Yamada T., Seishima M., Takami T., Takeuchi T. and Moriwaki H. (20150707). Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen. : Journal of clinical and experimental hematopathology : JCEH.

MLA

Goto Naoe, Tsurumi Hisashi, Takemura Masao, Matsumoto Takuro, Shibata Yuhei, Mabuchi Ryoko, Nakamura Nobuhiko, Nakamura Hiroshi, Yamada Tetsuya, Seishima Mitsuru, Takami Tsuyoshi, Takeuchi Tamotsu and Moriwaki Hisataka. Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen. : Journal of clinical and experimental hematopathology : JCEH. 20150707.